A. Sulpizio

发表

Antiinflammatory Activity in Animal Models Receptor That Demonstrates Antagonist of the Anaphylatoxin C3a Identification of a Selective Nonpeptide

McCafferty, J. Adams, K. Ward, 2001 .

Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II.

J. Hieble, A. Sulpizio, D. Colombo, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.

J. Hieble, A. Sulpizio, E. Poggesi, 1997, The Journal of pharmacology and experimental therapeutics.

Hypertensive End-Organ Damage and Premature Mortality Are p38 Mitogen-Activated Protein Kinase–Dependent in a Rat Model of Cardiac Hypertrophy and Dysfunction

John C. Lee, J. Adams, C. Angermann, 2001, Circulation.

Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

H. Sarau, R. Ames, N. Aiyar, 2000, British journal of pharmacology.

N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part

D. Demarini, D. Brooks, N. Laping, 2008, Journal of Pharmacology and Experimental Therapeutics.

Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.

Dwight M. Morrow, A. Sulpizio, R. Nagilla, 2009, Bioorganic & medicinal chemistry letters.

Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.

J. Hieble, J. Regan, A. Sulpizio, 1988, The Journal of pharmacology and experimental therapeutics.

GSK1016790A, a Novel and Potent TRPV4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I

D. Demarini, D. Brooks, N. Laping, 2008 .

In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.

J. Hieble, A. Sulpizio, D. Ashton, 1989, Pharmacology.

Antiinflammatory Activity in Animal Models Receptor That Demonstrates Antagonist of the Anaphylatoxin C3a Identification of a Selective Nonpeptide

McCafferty, J. Adams, K. Ward, 2001 .

Mechanism of Vasopeptidase Inhibitor-Induced Plasma Extravasation: Comparison of Omapatrilat and the Novel Neutral Endopeptidase 24.11/Angiotensin-Converting Enzyme Inhibitor GW796406

D. Brooks, A. Sulpizio, R. West, 2005, Journal of Pharmacology and Experimental Therapeutics.

Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.

R. Willette, J. Hieble, A. Sulpizio, 1988, The Journal of pharmacology and experimental therapeutics.

Nonpeptide Endothelin Antagonist: Cerebrovascular Characterization and Effects on Delayed Cerebral Vasospasm

R. Willette, E. Ohlstein, A. Sulpizio, 1994, Stroke.

The ocular hypotensive action of SK&F 86466 in the conscious rabbit.

J. Hieble, A. Sulpizio, W. D. Matthews, 1984, Current eye research.

The Effect of Acute Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition on Plasma Extravasation in the Rat

D. Brooks, A. Sulpizio, R. Edwards, 2004, Journal of Pharmacology and Experimental Therapeutics.

Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition.

A. Sulpizio, P. J. Fowler, E. Macko, 1978, Life sciences.

Pharmacological differentiation of pre- and post-junctional alpha 2-adrenoceptors.

J. Hieble, P. Lavanchy, A. Sulpizio, 1986, Journal of Hypertension - Supplement.

Identification, Characterization, and Functional Role of Phosphodiesterase Type IV in Cerebral Vessels: Effects of Selective Phosphodiesterase Inhibitors

R. Willette, E. Ohlstein, A. Sulpizio, 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models

J. Adams, K. Ward, H. Sarau, 2001, The Journal of Immunology.

Lack of a pharmacological distinction between alpha-1 adrenoceptors mediating intracellular calcium-dependent and independent contractions to sympathetic nerve stimulation in the perfused rat caudal artery.

J. Hieble, A. Sulpizio, 1991, The Journal of pharmacology and experimental therapeutics.

Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor α in rat uterine cells and tissues

N. Laping, A. Sulpizio, E. Grygielko, 2009, Steroids.

Pharmacologic differentiation between pre- and postjunctional α2-adrenoceptors by SK & F 104078

A. Sulpizio, P. Hieble, A. Nichols, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

SK&F 89124, A POTENT AND SELECTIVE AGONIST AT PREJUNCTIONAL DOPAMINE RECEPTORS

H. Sarau, J. Hieble, A. Sulpizio, 1989, Fundamental & clinical pharmacology.

Characterization of neuromedin U effects in canine smooth muscle.

J. Hieble, J. Disa, A. Sulpizio, 2002, Journal of Pharmacology and Experimental Therapeutics.

Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.

N. Aiyar, R. Willette, T. Yue, 1995, Proceedings of the National Academy of Sciences of the United States of America.

L‐carnitine intake and high trimethylamine N‐oxide plasma levels correlate with low aortic lesions in ApoE−/− transgenic mice expressing hCETP

A. Sulpizio, A. Bellamine, S. Adelman, 2016, Atherosclerosis.

A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.

Shawn P Williams, N. Laping, Shawn P. Williams, 2007, Molecular endocrinology.

The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.

R. Ruffolo, D. Brooks, E. Ohlstein, 1992, The Journal of pharmacology and experimental therapeutics.

The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.

J. Hieble, A. Sulpizio, D. Ashton, 1989, Chirality.

Demonstration of alpha 2-adrenoceptor-mediated contraction in the isolated canine saphenous artery treated with Bay K 8644.

J. Hieble, A. Sulpizio, 1987, European journal of pharmacology.

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

W. Bao, D. Behm, S. Nerurkar, 2008, Journal of Pharmacology and Experimental Therapeutics.

Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078.

J. Hieble, A. Sulpizio, A. Nichols, 1987, Naunyn-Schmiedeberg's archives of pharmacology.

Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.

J. Hieble, T. Blackburn, M. Wood, 1991, The Journal of pharmacology and experimental therapeutics.

Cardiovascular Effects of SK&F 104078, a Novel a‐Adrenoceptor Antagonist, in Normotensive and Hypertensive Rats

J. Hieble, A. Sulpizio, C. Gombar, 1990, Journal of cardiovascular pharmacology.

Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging.

D. Brooks, S. Lenhard, A. Sulpizio, 2007, Fertility and sterility.

Pharmacological profile of G619, a new platelet aggregation inhibitor.

T. Yue, G. Feuerstein, E. Ohlstein, 1992, Thrombosis research.

Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments.

G. Feuerstein, A. Sulpizio, A. Rudolph, 1997, Journal of applied physiology.